Intestinal bacteria contribute to the success of immunotherapy

Despite the success of cancer immunotherapy in some patients, others do not respond at all to its treatments and succumb to their disease. According to a recent study, these interindividual variations are caused by differences in the nature of the intestinal bacteria present in patients. Download the column

Share this content!

Recent Articles

Column Archives

Column Keywords